Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Regulators Critique MRI-Compatible Pacemaker

By R&D Editors | March 17, 2010

WASHINGTON (AP) – The Food and Drug Administration voiced several complaints with Medtronic’s study of a new pacemaker that can be used in an MRI machine.

Patients with pacemakers are generally discouraged from having MRI scans because the radio waves could interfere with the functioning of their device.

Medtronic has asked the FDA to approve its REVO Surescan pacemaker as the first device of its kind that can be safely used while undergoing such high-powered scans.

However, in documents posted online, the FDA complained that the company’s study suffered from a small population size and missing data.

Minneapolis-based Medtronic enrolled more than 500 patients with pacemakers and randomly assigned half of them to receive an MRI scan. Those patients were free of MRI-related complications, achieving the study’s goal.

But the FDA said the company did not provide detailed follow-up on many patients who enrolled in the study.

Medtronic said in a statement that some data were missing “due to that patient’s condition,” but that had no effect on the study results. The company also disputed the FDA’s comments about the small size of the study.

“We worked closely with the FDA in the design of our clinical trial and exceeded the minimum number of required trial participants,” said company spokeswoman Chris Garland.

The FDA will ask a panel of outside experts Friday whether Medtronic’s study showed the Surescan pacemaker is safe and effective.

The agency is not required to follow the group’s advice, though it often does.

Magnetic Resonance Imaging is one of the most widely used scanning technologies in medical practice. Physicians use the technique to diagnose problems in the brain, heart and other organs.

Pacemakers are implanted under the skin of the chest and use electric pulses to maintain a steady heart rhythm.

Date: March 16, 2010
Source: Associated Press

Related Articles Read More >

New nanopore sensor paves the way for fast, accurate, low-cost DNA sequencing
E. coli makes Tylenol from plastic waste
2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE